4 newer rulings cite the same tariff codes.

Classification can shift over time. Review the more recent rulings below before relying on this one.

N300527 N3 Ruling Active

The tariff classification of Solriamfetol (CAS No. 178429-62-4) in bulk powder form, from Italy

Issued October 1, 2018 by U.S. Customs and Border Protection.

Cite this ruling

Copies to clipboard

N3 N300527 (October 1, 2018)

Tariff classification

HTS codes: 2924.29.6250

Headings: 2924

Product description

Solriamfetol is a selective dopamine and norepinephrine reuptake inhibitor with wake-promoting effects. It is currently in phase III clinical trials for the treatment of excessive sleepiness associated with narcolepsy and sleep apnea (OSA).

CBP rationale

The applicable subheading for the Solriamfetol in bulk form will be 2924.29.6250, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Carboxyamide-function compounds; amide-function compounds of carbonic acid: Cyclic amides (including cyclic carbamates) and their derivatives; salts thereof: Other: Aromatic: Other: Drugs: Other: Other.

Full text

N300527 October 1, 2018 CLA-2-29:OT:RR:NC:N1:138 CATEGORY: Classification TARIFF NO.: 2924.29.6250 Ms. Sheila Heerdt Ren Pharm International Ltd. 350 Jericho Turnpike, Suite 204 Jericho, NY 11753 RE: The tariff classification of Solriamfetol (CAS No. 178429-62-4) in bulk powder form, from Italy Dear Ms. Heerdt In your letter dated, September 11, 2018, you requested a tariff classification ruling. Solriamfetol is a selective dopamine and norepinephrine reuptake inhibitor with wake-promoting effects. It is currently in phase III clinical trials for the treatment of excessive sleepiness associated with narcolepsy and sleep apnea (OSA). The applicable subheading for the Solriamfetol in bulk form will be 2924.29.6250, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Carboxyamide-function compounds; amide-function compounds of carbonic acid: Cyclic amides (including cyclic carbamates) and their derivatives; salts thereof: Other: Aromatic: Other: Drugs: Other: Other." The rate of duty will be 6.5 percent ad valorem. Currently, Solriamfetol is not listed in the Pharmaceutical Appendix to the Tarriff Schedule. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division

View original on CBP CROSS →

More rulings on the same tariff codes

Follow N300527

Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.

One email per day at most. Confirm your address once, unsubscribe anytime.

Searching CBP rulings the smart way

Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.